Obalon Therapeutics Inc (NASDAQ:OBLN) Director Kim P. Kamdar purchased 13,400 shares of Obalon Therapeutics stock in a transaction that occurred on Wednesday, October 12th. The shares were acquired at an average price of $15.00 per share, with a total value of $201,000.00. The purchase was disclosed in a legal filing with the SEC, which is available through this link.

Shares of Obalon Therapeutics Inc (NASDAQ:OBLN) traded up 0.23% during midday trading on Friday, hitting $13.00. The stock had a trading volume of 112,478 shares. The stock’s 50-day moving average price is $14.47 and its 200 day moving average price is $14.47. Obalon Therapeutics Inc has a 52 week low of $12.33 and a 52 week high of $15.88.

About Obalon Therapeutics

Obalon Therapeutics, Inc is a commercial-stage medical device company focused on developing and commercializing medical devices to treat obese and overweight people by facilitating weight loss. The Company’s product, Obalon balloon system, is a swallowable, gas-filled intragastric balloon designed to provide weight loss in obese patients.

5 Day Chart for NASDAQ:OBLN

Receive News & Stock Ratings for Obalon Therapeutics Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Obalon Therapeutics Inc and related stocks with our FREE daily email newsletter.